| Literature DB >> 24594284 |
Bertine M Fleerkotte1, Bram Koopman, Jaap H Buurke, Edwin H F van Asseldonk, Herman van der Kooij, Johan S Rietman.
Abstract
BACKGROUND: There is increasing interest in the use of robotic gait-training devices in walking rehabilitation of incomplete spinal cord injured (iSCI) individuals. These devices provide promising opportunities to increase the intensity of training and reduce physical demands on therapists. Despite these potential benefits, robotic gait-training devices have not yet demonstrated clear advantages over conventional gait-training approaches, in terms of functional outcomes. This might be due to the reduced active participation and step-to-step variability in most robotic gait-training strategies, when compared to manually assisted therapy. Impedance-controlled devices can increase active participation and step-to-step variability. The aim of this study was to assess the effect of impedance-controlled robotic gait training on walking ability and quality in chronic iSCI individuals.Entities:
Mesh:
Year: 2014 PMID: 24594284 PMCID: PMC3975927 DOI: 10.1186/1743-0003-11-26
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Figure 1LOPES robotic gait trainer.
Figure 2Hip and knee reference trajectories for the different walking speeds.
Figure 3Typical example of hip and knee reference trajectories and actual joint trajectories for a healthy subject walking at 2 km/h using different impedance levels. Increasing the impedance levels results in a closer approximation of the reference trajectory and a reduction in the movement variability between steps. Here, the reference knee angle is enlarged by 10 percent to ensure that the robot provides support (since the healthy subject is expected to walk according to the healthy reference trajectory).
Descriptive information of participants
| 37 | F | Th9 | C | 14 | |
| 50 | M | Th4 | D | 22 | |
| 29 | F | L2 | B** | 36 | |
| 60 | F | Th1 | C | 16 | |
| 48 | F | L2/Th12 | D | 122 | |
| 61 | M | C5 | D | 14 | |
| 56 | F | L1/L2 | C | 14 | |
| 31 | M | C5 | C | 120 | |
| 63 | M | C3/C2 | C | 16 | |
| 46 | F | C5 | D | 41 | |
| 51 | M | Th12 | D | 62 | |
| 53 | M | Th12 | C | 84 | |
| 48,75 ±11.3 | 46,75 ± 41.03 |
*Levels separated by a “/” indicate a difference in right and left level of injury. It is noted Right/Left.
**Diagnosed with a cauda equine syndrome.
***Dropouts.
Figure 4Training parameters as a function of the training duration. Training sessions are normalized to the total training time (0 percent start of training, 100 percent completion of training). Training duration refers to the actual total training time per session (excluding setup time and rest periods). Support levels are expressed as a percentage of the maximum stiffness that could be controlled by the LOPES (300 Nm/rad). BWS was only required in five of the 10 participants. The bars indicate the mean training parameters, averaged across participants, at the start of the training (0-10 percent) and at the end of the training period (90-100 percent). The error bars indicate the standard deviation.
Statistical results primary outcome measures
| | ||||||||
|---|---|---|---|---|---|---|---|---|
| Walking speed (m/s) | 90 | 0.61 | 0.67 | χ2(2) = 8.7 0.013* | 0.411 | 0.023 | 0.008* | 0.797 |
| Walking distance (m) | 100 | 184.4 | 212.9 | χ2(2) = 12.8 0.002* | 0.022 | 0.012* | 0.005* | 0.507 |
| TUG1 (s) | 100 | 19.5 | 16.1 | χ2(2) = 10.8 0.005* | 0.017* | 0.208 | 0.012* | 0.779 |
| WISCI-II | 30 | 13.5 | 14.4 | χ2(2) = 6.5 0.039* | 0.046 | 0.317 | 0.083 | 0.157 |
| LEMS | 90 | 34.4 | 37.8 | χ2(2) = 6.9 0.032* | 0.210 | 0.258 | 0.017* | 0.365 |
*Significant difference.
1The TUG was assessed in eight of 10 participants. Participants 7 and 9 were unable to stand up from the chair independently during the entire study.
Figure 5Primary outcomes. Measurements of walking ability were assessed pre-, mid-, and post-training and at follow-up. TUG could not be measured for subject 7 and 9. The bars indicate the mean clinical measures, averaged across participants, at each period. The error bars indicate the standard deviation.
Statistical results secondary outcome measures
| Walking speed (m/s) | | 89 | 0.49 | 0.56 | 0.015* |
| Cycle time (s) | | 11 | 2.24 | 2.04 | 0.032* |
| Step symmetry index (%) | | 22 | 8.46 (6.92) | 4.38 (3.28) | 0.021* |
| Step width (m) | | 33 | 0.11 | 0.10 | 0.114 |
| Step length (m) | Strong and weak | 89 | 0.44 | 0.47 | 0.017* |
| Strong | 78 | 0.46 | 0.48 | 0.027* | |
| Weak | 100 | 0.42 | 0.46 | 0.007* | |
| Rel. stance phase duration (%) | Strong and weak | 11 | 74.5 | 72.3 | 0.011* |
| Strong | 11 | 74.6 | 73.0 | 0.028* | |
| Weak | 0 | 74.4 | 71.5 | 0.008* | |
| Maximum knee flexion (swing) (deg) | Strong and weak | 56 | 48.6 | 48.4 | 0.859 |
| Strong | 56 | 49.3 | 50.7 | 0.314 | |
| Weak | 33 | 47.8 | 46.0 | 0.374 | |
| Knee ROM (initial and mid stance) (deg) | Strong and weak | 67 | 22.5 | 23.5 | 0.441 |
| Strong | 78 | 23.6 | 26.0 | 0.110 | |
| Weak | 67 | 21.5 | 21.8 | 0.953 | |
| Hip ROM (deg) | Strong and weak | 100 | 36.7 | 38,8 | 0.008* |
| Strong | 67 | 37.0 | 39.0 | 0.051 | |
| Weak | 89 | 36.4 | 38.7 | 0.011* |
*Significant difference.
Overview of studies using robotic gait training in patients with spinal cord injury
| Wirz et al., 2005 [ | N = 20 (4) Chronic Average: 70.8 months Lokomat | 8 weeks; 45 min; 3-5 ×/wk; (26 sessions) | 0.38 – 0.49* | 121 – 165* | 61 – 36* | No significant. increase | 32 – 35* (N=10) |
| Field-Fote et al, 2011 [ | N = 14 Chronic ≥ 12 month N = 14 Lokomat | 12 weeks; 45 min; 5 ×/wk; (49 sessions) | 0.17 – 0.18 | 50.4 – 53.7 | - | - | Left leg 12.7 – 13.9 Right leg 12.9 – 14.1* |
| Alcobendas-Maestro et al. 2012 [ | N = 37 (23) Sub-acute Average: 4 months Lokomat | 8 weeks; 30 min; 5 ×/wk; (40 sessions) | |||||
| Benito-Penalva et al. 2012 [ | N = 105 Sub-acute <6 month N = 81 6-12 month N = 8 >12 month N = 16 Lokomat (N = 39), GT (N = 66) | 8 weeks; 45 min; 5 ×/wk; (40 sessions) | 0.08 – 0.26* | - | - | 4.0-9.2* | 22.1-30.6* |
| Van Nunen et al. 2013 [ | N = 18 (9) Sub-acute and chronic <12 month N = 7 >12 month N = 11 Median: 28.8 months | 12 weeks; 60 min; 2 ×/wk; (24 sessions) (20-45 min) | - | No significant. Increase (N = 6) | No significant. increase | - | |
| Fleerkotte et al. | N = 10 Chronic Average: 45.3 months | 8 weeks; 60 min; 3 ×/wk; (20 sessions) (19 min) | 0.61 – 0.67* | 184.4 – 212.9* | 24.4 – 20.2* | 13.5 – 14.4 | 34.4 – 37.8* |
*Indicates a significant change.
N indicates the number of participants, (..) the number of individuals initially unable to walk over the full 10 m walkway.
Median, mean.